E. Ohman J:or Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

E. Ohman J:or Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-900	Closed	-$219K	–	407
2025 Q1	$219K	Hold	900	–	–	0.01%	412
2024 Q4	$296K	Hold	900	–	–	0.01%	418
2024 Q3	$301K	Hold	900	–	–	0.01%	395
2024 Q2	$246K	Buy	900 +500	+125%	+$145K	0.01%	407
2024 Q1	$138K	Hold	400	–	–	﹤0.01%	420
2023 Q4	$129K	Hold	400	–	–	﹤0.01%	407
2023 Q3	$143K	Buy	+400	New	+$154K	0.01%	414
2022 Q3	–	Sell	-1,100	Closed	-$545K	–	428
2022 Q2	$545K	Sell	1,100 -13,600	-93%	-$7.08M	0.02%	339
2022 Q1	$8.28M	Sell	14,700 -3,300	-18%	-$1.99M	0.28%	62
2021 Q4	$13.6M	Sell	18,000 -954	-5%	-$714K	0.39%	50
2021 Q3	$14.1M	Buy	18,954 +1,500	+9%	+$1.12M	0.44%	47
2021 Q2	$11.2M	Buy	17,454 +16,500	+1,730%	+$10M	0.35%	54
2021 Q1	$545K	Hold	954	–	–	0.02%	360
2020 Q4	$556K	Hold	954	–	–	0.02%	315
2020 Q3	$492K	Buy	954 +300	+46%	+$152K	0.02%	290
2020 Q2	$295K	Hold	654	–	–	0.02%	347
2020 Q1	$229K	Sell	654 -600	-48%	-$221K	0.02%	342
2019 Q4	$464K	Buy	+1,254	New	+$442K	0.03%	314

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

E. Ohman J:or Asset Management's BIO Position: Q2 2025 in Review

E. Ohman J:or Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 900 shares — an estimated $219K sold.

E. Ohman J:or Asset Management first reported a position in BIO in Q4 2019 and held it in 18 quarters. The position peaked at $14.1M in Q3 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

E. Ohman J:or Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
E. Ohman J:or Asset Management sold 900 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $219K.
E. Ohman J:or Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 18 quarters.
E. Ohman J:or Asset Management's Bio-Rad Laboratories Class A position peaked at $14.1M in Q3 2021.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2025, filed 8 Jul 2025.